Corvus Pharmaceuticals Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
Corvus Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 8, 2018 9:20 PM EDT
Corvus Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 7,058,824 shares of its common stock at a price to the public of $8.50 per share.
In this article: CRVS
Read
Staying Cautious On Corvus Pharma IPO
Article By: Don Dion
Wednesday, March 23, 2016 12:28 PM EDT
Based in Burlingame, California, CRVS is a clinical stage biopharmaceutical company, focused on immune-based cancer treatments. We suggest holding off, particularly given the sluggish IPO market.
In this article: CRVS
Read
Corvus Announces Pricing Of Initial Public Offering
Article By: NASDAQ GlobeNewswire
Wednesday, March 23, 2016 4:13 AM EDT
Corvus Pharmaceuticals will IPO on Wednesday March 23; offering price for 4.7 million shares is $15.
In this article: CRVS
Read

Latest Tweets for $CRVS

No tweets yet!